PARP1 and Parkinson disease: In conclusion, we found that MPP+ and MPTP can cause parthanatos and calcitriol can alleviate this through the VDR/PARP1 pathway, showing a new mechanism of calcitriol and providing new insights into the pathogenesis and treatment of PD.